| (Values in U.S. Thousands) | Feb, 2022 | Feb, 2021 | Feb, 2020 | Feb, 2019 | Feb, 2018 |
| Sales | 18,312 | -34 | 352 | 3,147 | 3,939 |
| Sales Growth | +54,686.90% | -109.53% | -88.81% | -20.11% | -0.14% |
| Net Income | -4,372 | -2,667 | -2,341 | -761 | -8,060 |
| Net Income Growth | -63.90% | -13.93% | -207.84% | +90.56% | +6.95% |
Salona Global Medical Device Corp (SGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Salona Global Medical Device Corp is us based, acquisition-focused medical device company. SGMD plans to continue to acquire small, private medical device companies and expand their revenues globally post-acquisition. SGMD has a solid balance sheet, a deep acquisition pipeline and a team (former DJO & PHM) with a strong track record of both inorganic growth through acquisitions and organic growth through the development of global sales, economies of scope, and economies of scale. It has one segment healthcare operations.